Ohtuvayre is the first inhaled product with a novel mechanism of action available for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients in more than 20 years.

Ohtuvayre is the first inhaled product with a novel mechanism of action available for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients in more than 20 years.

Hines, a researcher at Queensland University of Technology, has reported that they have discovered part of the mechanism by which general anesthesia ... released by the action of specific proteins ...

urging medical centers to take action to mitigate greenhouse gas emissions from inhaled anesthetics, in particular desflurane and nitrous oxide. UCSF's early action has impressed Hamid.

“By studying four anesthetics with different mechanisms of action in a comparable experimental setup, we aimed to find possible similarities and dissimilarities in their brain effects. Including the ...

"By studying four anesthetics with different mechanisms of action in a comparable experimental setup, we aimed to find possible similarities and dissimilarities in their brain effects. Including ...

today announced exciting new proof-of-mechanism data from the company’s Phase 1b Inhaled LPS clinical trial of RLS-0071 presented at the American Thoracic Society International Conference on May 23, ...

Aridis Pharmaceuticals Inc's (NASDAQ: ARDS) inhaled treatment of its fully ... neutralizes coronaviruses using a distinct mechanism of action: inhibition of viral fusion and entry into human ...

Anesthesiologists can help reduce greenhouse gas emissions by replacing inhaled anesthetics ... Some hospitals are taking action to cut emissions from volatile anesthetics and reduce waste.